Vimarsana
Biggest News Aggregation in the World

Janssen Scientific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janssen Scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janssen Scientific Today - Breaking & Trending Today

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia - Vimarsana News

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

This study reports the results of 3 randomized, double-masked, placebo-controlled substudies of abatacept, cenicriviroc, and infliximab plus standard care for C

Beyond Biotech podcast 29: Janssen, Knowledge Gate - Vimarsana News

Beyond Biotech podcast 29: Janssen, Knowledge Gate

This week, our guests are Viktoriya Vasilenko, from Knowledge Gate, and Avery Ince, from Janssen Scientific Affairs.

Improvements in Treatment-Resistant Depression With Esketamine - Vimarsana News

Improvements in Treatment-Resistant Depression With Esketamine

Pooled data from randomized trials showed better scores on the PHQ-9 as well

Lack of Consensus Among Guidelines for LAI Antipsychotics for First-Episode Schizophrenia - Vimarsana News

Lack of Consensus Among Guidelines for LAI Antipsychotics for First-Episode Schizophrenia

Although guidelines recommend antipsychotics for first-episode schizophrenia, only 1 guideline recommends LAI as the delivery method of choice.